ASTEX THERAPEUTICS LTD
Patent Owner
Stats
- 74 US PATENTS IN FORCE
- 7 US APPLICATIONS PENDING
- Mar 13, 2018 most recent publication
Details
- 74 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,041 Total Citation Count
- Sep 09, 2002 Earliest Filing
- 80 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0065,959 BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPYAug 11, 17Mar 08, 18[A61K, C07D]
2018/0021,332 PHARMACEUTICAL COMPOSITIONS COMPRISING N-(3,5-DIMETHOXYPHENYL)-N'-(1-METHYLETHYL)-N-[3-(1-METHYL-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1,2-DIAMINEFeb 09, 16Jan 25, 18[A61K]
2017/0334,907 BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPYMay 03, 17Nov 23, 17[A61K, C07D]
2016/0039,832 SALT(S) OF 7-CYCLOPENTYL-2-(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID DIMETHYLAMIDE AND PROCESSES OF MAKING THEREOFOct 20, 15Feb 11, 16[C07D, C07C]
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0288,040 SUBSTITUTED BENZYLAMINE COMPOUNDS, THEIR USE IN MEDICINE, AND IN PARTICULAR THE TREATMENT OF HEPATITIS C VIRUS (HCV) INFECTIONAbandonedOct 31, 12Sep 25, 14[A61K, C07D, C07C]
2014/0010,892 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORSAbandonedMay 24, 13Jan 09, 14[A61K, C07D]
8598217 Imidazole derivatives and their use as modulators of cyclin dependent kinasesExpiredApr 30, 10Dec 03, 13[A61K, C07D, A61P]
8541461 Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulatorsExpiredJun 21, 06Sep 24, 13[A61K]
8435970 Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-ureaExpiredJun 29, 07May 07, 13[A61K]
8110573 Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinasesExpiredDec 30, 05Feb 07, 12[A61K, C07D]
2011/0224,203 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORSAbandonedMay 26, 11Sep 15, 11[A61K, A61P]
7977477 Benzimidazole derivatives and their use as protein kinase inhibitorsExpiredJul 05, 04Jul 12, 11[A61K, C07D]
7951819 Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compoundsExpiredApr 26, 07May 31, 11[A61K, A01N, C07D]
2010/0324,072 PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS BACE INHIBITORSAbandonedMay 14, 08Dec 23, 10[A61K, C07D, A61P]
2010/0298,340 Thiazol-Guanidine Derivatives Useful As A (Beta)-Related PathologiesAbandonedApr 12, 07Nov 25, 10[A61K, C07D, C12N, C07C, A61P]
2010/0210,617 Aryl-Alkylamines And Heteroaryl-Alkylamines As Protein Kinase InhibitorsAbandonedJun 21, 06Aug 19, 10[A61K, C07D, A61P]
2010/0160,324 PYRAZOLE DERIVATIVES AS THAT MODULATE THE ACTIVITY OF CDK, GSK AND AURORA KINASESAbandonedDec 30, 05Jun 24, 10[A61K, C07D, A61P]
2010/0120,798 SUBSTITUTED PIPERIDINES CONTAINING A HETEROARYLAMIDE OR HETEROARYLPHENYL MOIETYAbandonedDec 20, 07May 13, 10[A61K, C07D, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.